Our Science Partner With Us

Partner with us

We’re committed to building sustainable relationships across the scientific and business communities that help us combine transformative advances in the understanding of human disease with the science of therapeutics, all with the goal of advancing human health.

Submit an inquiry

Female scientist speaks with business partner

Submit an inquiry

Collaboration defines our culture

We know that collaborating with the world’s experts is a cornerstone to solving some of science’s most difficult problems. Collaboration is one of our core values at Vertex — it defines our culture.

Show All

two female business partners in a meeting

Externally, our collaborations with companies, academia, research organizations and nonprofit organizations help drive scientific innovation and the development of new medicines.

Internally, it creates an environment that encourages the open exchange of ideas and provides the freedom for our talented employees to explore new scientific concepts.

Show All

Partnerships enhance scientific innovation

To support our mission, we seek external partnerships that promote scientific innovation. We believe that innovation should not be limited to opportunities based on specific stages of development or particular treatment modalities, but instead, focused on creating relationships that are grounded in deep biological knowledge of the disease and target. Our sense of urgency for patients drives us to seek the best of the best, inside and outside of Vertex’s walls, to achieve our goals as fast as possible.

An image of a Vertex lab with a computer screen and a chair with a blue lab coat resting on the back. There are vials, beakers, and molecule models on the table next to the computer screen.

Our current priorities include:

Supporting Vertex’s R&D strategy of bringing innovative medicines to patients by complementing our existing research efforts and clinical assets with additional tools and/or technologies.
Diversifying our portfolio with potentially transformative medicines for diseases where there is a high unmet need.
Leveraging cutting-edge technology platforms to accelerate the discovery of new disease targets, compounds, delivery mechanisms and potential treatment modalities.
Maximizing the potential of Vertex programs by using strategic collaborations and licensing opportunities to enable speedy and thorough development.

Show All

Vertex is a trusted partner

Show All

Female businesswoman speaking in meeting

We value developing strategic relationships that are mutually beneficial. Our approach is to create successful partnerships with well-articulated principles and value propositions. Our portfolio of alliances consists of a variety of collaboration models to meet the different needs of our partners.

Vertex works to maximize the value of our partnerships, seeking to make decisions that align our common goals and, most importantly, bring benefits to patients as quickly as possible. We work collaboratively to make informed and strategic decisions to rapidly progress our partnered programs.

Show All

Areas of interest

We're actively exploring all approaches that may change the treatment of a serious disease where no adequate treatment currently exists. We are seeking technologies that will enable exploration of new diseases or disease targets.

Please also contact us if you'd like to explore a potential partnership related to any of the following:

Show All

Alpha-1 antitrypsin deficiency (AATD)

APOL1-mediated kidney disease (AMKD)

Autosomal dominant polycystic kidney disease (ADPKD)

Beta thalassemia

Show All

Cystic fibrosis

Duchenne muscular dystrophy icon in pink and purple

Duchenne muscular dystrophy (DMD)

IgA nephropathy (IgAN)

Myotonic dystrophy type 1 (DM1)

Show All

Pain

Sickle cell disease (SCD)

Type 1 diabetes (T1D)

Show All

Partner with us

White background

Show All

Our global network of innovation

External collaborations expand our drug discovery toolbox and further our commitment to transforming serious diseases. We have partnerships in cell and genetic therapies, innovation in small molecule and intracellular therapeutics, targets and human cell models, and other areas. Learn more about our current partnerships below.

Show All